CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
Revenue
Orthopedic product sales	$ 17,830	$ 21,996
Other revenue	104	87
Total Revenue	17,934	22,083
Cost of sales	5,702	7,176
Gross Profit	12,232	14,907
Operating Expenses
General and administrative	3,025	4,128
Sales and marketing	8,349	10,997
Research and development	414	699
Depreciation and amortization	1,004	1,281
Restructuring expenses	733	0
Separation related expenses	0	224
Non-cash compensation expense	364	145
Total Operating Expenses	13,889	17,474
Loss from Operations	(1,657)	(2,567)
Other (Expense) Income
Interest expense	(3,545)	(3,400)
Change in warrant derivative liability	(38)	170
Other (expense) income	(13)	12
Total Other (Expense)	(3,596)	(3,218)
Net Loss from Operations	$ (5,253)	$ (5,785)
Net loss per share:
Basic	$ (0.7)	$ (3.87)
Dilutive	$ (0.7)	$ (3.87)
Shares used in the computation:
Basic	7,481,550	1,494,443
Dilutive	7,481,550	1,494,443